1
|
Muvengwi J, Mbiba M. Medicinal plants trade in Harare's urban markets: diversity, conservation status, and economic significance. JOURNAL OF ETHNOBIOLOGY AND ETHNOMEDICINE 2025; 21:28. [PMID: 40275311 DOI: 10.1186/s13002-025-00778-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/11/2025] [Accepted: 04/02/2025] [Indexed: 04/26/2025]
Abstract
BACKGROUND Urban markets serve as crucial centres for trading traditional medicinal plants, yet there is limited research on the diversity, geographic origins, and socio-economic contributions of these plants. Therefore, this study aimed at understanding the species composition and diversity, conservation status, and economic importance of medicinal plants in urban markets of Harare, Zimbabwe, to provide insights into their sustainability and cultural significance. METHODS This study surveyed medicinal plant vendors in three major urban markets in Harare, Mbare, Highfield, and the Central Business District (CBD) in 2019 over a period of three months. Data were collected through semi-structured questionnaires to inventory medicinal plant species, document vendors' districts of origin, and assess harvesting practices. Species diversity was analysed using Shannon-Wiener and Simpson diversity indices, while Non-metric Multidimensional Scaling (NMDS) was used to compare species composition across markets. The informant consensus factor (ICF) was calculated to determine the level of agreement among vendors on the medicinal use of plant species. RESULTS A total of 64 medicinal plant species were identified, with Fabaceae being the most represented family. Sixty-one species were in the least concern IUCN Red List category. Key species with high use reports included Entada goetzei (62), Cassia abbreviata (58), Pterocarpus angolensis (40), and Albizia anthelmintica (31). Roots were the most sold plant part, followed by bark and leaves. Mbare exhibited the highest species richness (54), followed by Highfield (34), while the CBD recorded the lowest richness (23). Non-metric Multidimensional Scaling (NMDS) analysis revealed distinct differences in species composition among the three markets (R = 0.492), with Highfield displaying a unique suit of medicinal plant species. Vendors primarily originated and sourced their medicinal plants from eastern Zimbabwe, particularly Chipinge, highlighting a strong link between plant sourcing and geographic origin. The ICF was highest for gastrointestinal disorders (0.807), women's health (0.778), sexually transmitted infections (0.746), and labour-related ailments (0.842). Medicinal plant trade contributed significantly to vendors' livelihoods, with monthly incomes ranging from US$150 to $300. CONCLUSION This study underscores the high diversity of medicinal plants and their socio-economic importance in Harare's urban markets. This shows that traditional medicine is still considered important in primary health care in the city of Harare. However, the reliance on distant districts (~ ≥ 100 km) for plant sourcing raises concerns about the possibility of unknowingly overharvesting.
Collapse
Affiliation(s)
- Justice Muvengwi
- School of Animal, Plant and Environmental Sciences, University of the Witwatersrand, Private Bag 3, Johannesburg, 2050, Wits, South Africa.
| | - Monicah Mbiba
- School of Animal, Plant and Environmental Sciences, University of the Witwatersrand, Private Bag 3, Johannesburg, 2050, Wits, South Africa
| |
Collapse
|
2
|
Smith DJ, Bi H, Hamman J, Ma X, Mitchell C, Nyirenda K, Monera-Penduka T, Oketch-Rabah H, Paine MF, Pettit S, Pheiffer W, Van Breemen RB, Embry M. Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries. Front Pharmacol 2023; 14:1210579. [PMID: 37502215 PMCID: PMC10368978 DOI: 10.3389/fphar.2023.1210579] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2023] [Accepted: 06/30/2023] [Indexed: 07/29/2023] Open
Abstract
The COVID-19 pandemic sparked the development of novel anti-viral drugs that have shown to be effective in reducing both fatality and hospitalization rates in patients with elevated risk for COVID-19 related morbidity or mortality. Currently, nirmatrelvir/ritonavir (Paxlovid™) fixed-dose combination is recommended by the World Health Organization for treatment of COVID-19. The ritonavir component is an inhibitor of cytochrome P450 (CYP) 3A, which is used in this combination to achieve needed therapeutic concentrations of nirmatrelvir. Because of the critical pharmacokinetic effect of this mechanism of action for Paxlovid™, co-administration with needed medications that inhibit or induce CYP3A is contraindicated, reflecting concern for interactions with the potential to alter the efficacy or safety of co-administered drugs that are also metabolized by CYP3A. Some herbal medicines are known to interact with drug metabolizing enzymes and transporters, including but not limited to inhibition or induction of CYP3A and P-glycoprotein. As access to these COVID-19 medications has increased in low- and middle-income countries (LMICs), understanding the potential for herb-drug interactions within these regions is important. Many studies have evaluated the utility of herbal medicines for COVID-19 treatments, yet information on potential herb-drug interactions involving Paxlovid™, specifically with herbal medicines commonly used in LMICs, is lacking. This review presents data on regionally-relevant herbal medicine use (particularly those promoted as treatments for COVID-19) and mechanism of action data on herbal medicines to highlight the potential for herbal medicine interaction Herb-drug interaction mediated by ritonavir-boosted antiviral protease inhibitors This work highlights potential areas for future experimental studies and data collection, identifies herbal medicines for inclusion in future listings of regionally diverse potential HDIs and underscores areas for LMIC-focused provider-patient communication. This overview is presented to support governments and health protection entities as they prepare for an increase of availability and use of Paxlovid™.
Collapse
Affiliation(s)
- Dallas J. Smith
- Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, United States
- COVID-19 Response International Task Force, Centers for Disease Control and Prevention, Atlanta, GA, United States
| | - Huichang Bi
- School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China
| | - Josias Hamman
- Centre of Excellence for Pharmaceutical Sciences (Pharmacen™), Faculty of Health Sciences, North-West University, Potchefstroom, South Africa
| | - Xiaochao Ma
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, United States
| | - Constance Mitchell
- Health and Environmental Sciences Institute, Washington, DC, United States
| | - Kumbukani Nyirenda
- Department of Pharmacy, Kamuzu University of Health Sciences, Blantyre, Malawi
| | - Tsitsi Monera-Penduka
- Research Unit for Safety of Herbs and Drugs, University of Zimbabwe, Harare, Zimbabwe
| | | | - Mary F. Paine
- Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, United States
| | - Syril Pettit
- Health and Environmental Sciences Institute, Washington, DC, United States
| | - Wihan Pheiffer
- DSI/NWU Preclinical Drug Development Platform, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa
| | - Richard B. Van Breemen
- Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR, United States
| | - Michelle Embry
- Health and Environmental Sciences Institute, Washington, DC, United States
| |
Collapse
|
3
|
Mongalo NI, Raletsena MV, Munyai R. In Vitro Pharmacological Activity, and Comparison GC-ToF-MS Profiling of Extracts from Cissus cornifolia (Baker) Planch. Life (Basel) 2023; 13:life13030728. [PMID: 36983882 PMCID: PMC10059918 DOI: 10.3390/life13030728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2023] [Revised: 02/17/2023] [Accepted: 03/05/2023] [Indexed: 03/30/2023] Open
Abstract
Cissus cornifolia (Baker) Planch is traditionally used in South African traditional medicine (SATM) to treat a variety of human infections. The antimicrobial activity of extracts from C. cornifolia was investigated in vitro against a plethora of pathogenic microorganisms using the microdilution assay. The acetone extract exhibited a notable minimum inhibitory concentration (MIC) value of 0.10 mg/mL against Mycoplasma hominis and a further MIC of 0.20 mg/mL against Candida parapsilosis, Streptococcus agalactiae, Pseudomonas aeruginosa, and Enterococcus faecalis. In the antiproliferative assays, both the ethyl acetate and methanol extracts exhibited a potent inhibition of the MCF-7-21 cell line. In the anti-inflammatory assays, both the ethyl acetate and methanol extracts exhibited IC50 values of 15.59 and 15.78 µg/mL against Cyclooxygenase-2 (COX-2), respectively. Methanol extract further exhibited potent dual inhibition of both COX-2 and 15-LOX enzymes, hence, recommended to curb both related cancers, particularly breast cancer and inflammation-borne diseases. In the comparative gas chromatography time-of-flight mass spectrometry (GC/TOF-MS), the acetone, ethyl acetate, and methanol extract contained significantly prevalent amounts of compound 2-(2',4',4',6',6',8',8'-Heptamethyltetrasiloxan-2'-yloxy)-2,4,4,6,6,8,8,10,10-nonamethylcyclopentasiloxane with % area ranging from 15.714 to 39.225. The findings in the current work validates the use of the plant species in SATM in the treatment of cancer-like infections, opportunistic infections associated with HIV-AIDS. Furthermore, the in vivo studies and the mechanisms of action still need to be explored.
Collapse
Affiliation(s)
- Nkoana I Mongalo
- College of Agriculture and Environmental Sciences Laboratories, University of South Africa, Private Bag X06, Florida 0610, South Africa
| | - Maropeng Vellry Raletsena
- Department of Agriculture and Animal Health, College of Agriculture and Environmental Sciences Horticulture Centre, University of South Africa, Private Bag X6, Florida 1710, South Africa
| | - Rabelani Munyai
- Department of Agriculture and Animal Health, College of Agriculture and Environmental Sciences Horticulture Centre, University of South Africa, Private Bag X6, Florida 1710, South Africa
| |
Collapse
|
4
|
Mongalo NI, Raletsena MV. An Inventory of South African Medicinal Plants Used in the Management of Sexually Transmitted and Related Opportunistic Infections: An Appraisal and Some Scientific Evidence (1990-2020). PLANTS (BASEL, SWITZERLAND) 2022; 11:3241. [PMID: 36501281 PMCID: PMC9738887 DOI: 10.3390/plants11233241] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/10/2022] [Revised: 11/07/2022] [Accepted: 11/11/2022] [Indexed: 06/17/2023]
Abstract
The current work is aimed at generating the first inventory of South African medicinal plants used in the treatment of sexually transmitted and related opportunistic infections associated with HIV-AIDS. This is important in assisting researchers to access a list of plant species to evaluate for potential phytocompounds, as this area of research is greatly lagging in South Africa. A total of 335 medicinal plants from 103 families have been documented in the current work. The most represented families are Fabaceae (11.64%) and Asteraceae (6.27%). Herbs constitute 36.53%, trees 32.34%, shrubs 29.04%, climbers 1.80% and parasites 0.30%. It is worrying that on the plant parts used, the roots constitute 47.18%, while leaves and stem bark yield 16.62 and 15.01%, respectively. Catharanthus roseus exhibited the highest number of citations (19), while Peltophorum africanum had 14 and both Carica papaya and Vachelia karoo had 12. In the mode of administration of the reported medicinal plant species, most of the plants are boiled and taken orally (48.22%), while other plant species are used as mouth washes (3.25%). Although there is reasonable in vitro activity of some of the plant species, validating the relevance of use, there is still a need to explore the mode of action of such plant species; isolated compounds and possible derivatives thereof are of paramount importance and need to be explored as well. Furthermore, toxicological aspects of such plant species need to be explored.
Collapse
Affiliation(s)
- Nkoana I. Mongalo
- The College of Agriculture and Environmental Sciences (CAES), University of South Africa, Johannesburg 2092, South Africa
| | | |
Collapse
|
5
|
Schwartz ZT, Theisen PD, Bjornstal OT, Rodebaugh M, Jemal MA, Lee D, Shelton SD, Zhao Z, Du L, Kerwin SM. Scalable Synthesis and Cancer Cell Cytotoxicity of Rooperol and Analogues. MOLECULES (BASEL, SWITZERLAND) 2022; 27:molecules27061792. [PMID: 35335155 PMCID: PMC8949049 DOI: 10.3390/molecules27061792] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Revised: 02/28/2022] [Accepted: 03/04/2022] [Indexed: 11/16/2022]
Abstract
Plant polyphenols, such as the African potato (Hypoxis hemerocallidea)-derived bis-catechol rooperol, can display promising anticancer activity yet suffer from rapid metabolism. Embarking upon a program to systematically examine potentially more metabolically stable replacements for the catechol rings in rooperol, we report here a general, scalable synthesis of rooperol and analogues that builds on our previous synthetic approach incorporating a key Pd-catalyzed decarboxylative coupling strategy. Using this approach, we have prepared and evaluated the cancer cell cytotoxicity of rooperol and a series of analogues. While none of the analogues examined here were superior to rooperol in preventing the growth of cancer cells, analogues containing phenol or methylenedioxyphenyl replacements for one or both catechol rings were nearly as effective as rooperol.
Collapse
Affiliation(s)
- Zachary T. Schwartz
- Department of Chemistry & Biochemistry, Texas State University, San Marcos, TX 78666, USA; (Z.T.S.); (P.D.T.); (M.R.); (M.A.J.); (D.L.); (S.D.S.); (Z.Z.); (L.D.)
| | - Peter D. Theisen
- Department of Chemistry & Biochemistry, Texas State University, San Marcos, TX 78666, USA; (Z.T.S.); (P.D.T.); (M.R.); (M.A.J.); (D.L.); (S.D.S.); (Z.Z.); (L.D.)
| | - Olaf T. Bjornstal
- Division of Chemical Biology and Medicinal Chemistry, University of Texas at Austin, Austin, TX 78712, USA;
| | - Mary Rodebaugh
- Department of Chemistry & Biochemistry, Texas State University, San Marcos, TX 78666, USA; (Z.T.S.); (P.D.T.); (M.R.); (M.A.J.); (D.L.); (S.D.S.); (Z.Z.); (L.D.)
| | - Mauricio A. Jemal
- Department of Chemistry & Biochemistry, Texas State University, San Marcos, TX 78666, USA; (Z.T.S.); (P.D.T.); (M.R.); (M.A.J.); (D.L.); (S.D.S.); (Z.Z.); (L.D.)
- Materials Science, Engineering, and Commercialization Program, Texas State University, San Marcos, TX 78666, USA
| | - Dallas Lee
- Department of Chemistry & Biochemistry, Texas State University, San Marcos, TX 78666, USA; (Z.T.S.); (P.D.T.); (M.R.); (M.A.J.); (D.L.); (S.D.S.); (Z.Z.); (L.D.)
| | - Spencer D. Shelton
- Department of Chemistry & Biochemistry, Texas State University, San Marcos, TX 78666, USA; (Z.T.S.); (P.D.T.); (M.R.); (M.A.J.); (D.L.); (S.D.S.); (Z.Z.); (L.D.)
| | - Zhenze Zhao
- Department of Chemistry & Biochemistry, Texas State University, San Marcos, TX 78666, USA; (Z.T.S.); (P.D.T.); (M.R.); (M.A.J.); (D.L.); (S.D.S.); (Z.Z.); (L.D.)
| | - Liqin Du
- Department of Chemistry & Biochemistry, Texas State University, San Marcos, TX 78666, USA; (Z.T.S.); (P.D.T.); (M.R.); (M.A.J.); (D.L.); (S.D.S.); (Z.Z.); (L.D.)
| | - Sean M. Kerwin
- Department of Chemistry & Biochemistry, Texas State University, San Marcos, TX 78666, USA; (Z.T.S.); (P.D.T.); (M.R.); (M.A.J.); (D.L.); (S.D.S.); (Z.Z.); (L.D.)
- Division of Chemical Biology and Medicinal Chemistry, University of Texas at Austin, Austin, TX 78712, USA;
- Materials Science, Engineering, and Commercialization Program, Texas State University, San Marcos, TX 78666, USA
- Correspondence: ; Tel.: +1-5122452056
| |
Collapse
|
6
|
Di Sotto A, Vitalone A, Di Giacomo S. Plant-Derived Nutraceuticals and Immune System Modulation: An Evidence-Based Overview. Vaccines (Basel) 2020; 8:E468. [PMID: 32842641 PMCID: PMC7563161 DOI: 10.3390/vaccines8030468] [Citation(s) in RCA: 48] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2020] [Revised: 08/17/2020] [Accepted: 08/19/2020] [Indexed: 12/15/2022] Open
Abstract
Immunomodulators are agents able to affect the immune system, by boosting the immune defences to improve the body reaction against infectious or exogenous injuries, or suppressing the abnormal immune response occurring in immune disorders. Moreover, immunoadjuvants can support immune system acting on nonimmune targets, thus improving the immune response. The modulation of inflammatory pathways and microbiome can also contribute to control the immune function. Some plant-based nutraceuticals have been studied as possible immunomodulating agents due to their multiple and pleiotropic effects. Being usually more tolerable than pharmacological treatments, their adjuvant contribution is approached as a desirable nutraceutical strategy. In the present review, the up to date knowledge about the immunomodulating properties of polysaccharides, fatty acids and labdane diterpenes have been analyzed, in order to give scientific basic and clinical evidence to support their practical use. Since promising evidence in preclinical studies, limited and sometimes confusing results have been highlighted in clinical trials, likely due to low methodological quality and lacking standardization. More investigations of high quality and specificity are required to describe in depth the usefulness of these plant-derived nutraceuticals in the immune system modulation, for health promoting and disease preventing purposes.
Collapse
Affiliation(s)
- Antonella Di Sotto
- Department of Physiology and Pharmacology, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy;
| | - Annabella Vitalone
- Department of Physiology and Pharmacology, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy;
| | | |
Collapse
|